KDM1A and neuroblastoma: LSD1 is ubiquitously overexpressed in numerous cancers, including acute myeloid leukemia (AML), breast cancer, prostate cancer, neuroblastoma, and small cell lung cancer (SCLC), and its overexpression associates with the initiation and progression of malignant tumors and the overall survival time of patients [7, 8].